XML 47 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
Intangible Assets and Royalty Agreement - Summary of Intangible Assets (Details) - USD ($)
9 Months Ended
Jan. 29, 2007
Sep. 30, 2017
Dec. 31, 2016
Jan. 13, 2016
Jan. 05, 2011
Finite-Lived Intangible Assets [Line Items]          
Total   $ 16,887,000 $ 30,260,000    
Less Accumulated amortization and impairment charges   (6,510,000) (6,992,000)    
Net   10,377,000 23,268,000    
Tradenames & trademarks          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived   1,008,000 1,458,000    
Tradenames & trademarks | Stability Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived       $ 450,000  
Tradenames & trademarks | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived         $ 1,008,000
In process research & development          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived   25,000 25,000    
In process research & development | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived         25,000
Patents in process          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived   $ 1,742,000 2,618,000    
Licenses          
Finite-Lived Intangible Assets [Line Items]          
Weighted average amortization lives   7 years      
Gross carrying value   $ 1,009,000 1,399,000    
Licenses | Stability Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value       390,000  
Licenses | Shriners Hospitals for Children and University of South Florida Research Foundation, Inc.          
Finite-Lived Intangible Assets [Line Items]          
Acquisition price $ 996,000        
Maximum time of approval 30 days        
Fair value of earn-out $ 200,000        
Contingent royalty to be paid to licensor 3.00%        
Annual royalty payment, minimum $ 50,000        
Licenses | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value         13,000
Patents and know-how          
Finite-Lived Intangible Assets [Line Items]          
Weighted average amortization lives   19 years      
Gross carrying value   $ 8,712,000 14,839,000    
Patents and know-how | Stability Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value       6,790,000  
Patents and know-how | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value         7,690,000
Finite lived intangible assets   $ 663,000      
Customer & supplier relationships          
Finite-Lived Intangible Assets [Line Items]          
Weighted average amortization lives   13 years      
Gross carrying value   $ 4,271,000 9,091,000    
Customer & supplier relationships | Stability Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value       5,330,000  
Customer & supplier relationships | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value         $ 3,761,000
Non compete agreements          
Finite-Lived Intangible Assets [Line Items]          
Weighted average amortization lives   4 years      
Gross carrying value   $ 120,000 $ 830,000    
Non compete agreements | Stability Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value       $ 830,000